Hygeia Healthcare Holdings Yönetim

Yönetim kriter kontrolleri 4/4

Hygeia Healthcare Holdings CEO'su Yiwen Zhu, Aug2021 tarihinde atandı, in görev süresi 3.25 yıldır. in toplam yıllık tazminatı CN¥ 2.49M olup, şirket hissesi ve opsiyonları dahil olmak üzere 24.1% maaş ve 75.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 44.98% ine doğrudan sahiptir ve bu hisseler HK$ 4.60B değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 5 yıldır.

Anahtar bilgiler

Yiwen Zhu

İcra Kurulu Başkanı

CN¥2.5m

Toplam tazminat

CEO maaş yüzdesi	24.1%
CEO görev süresi	3.3yrs
CEO sahipliği	45.0%
Yönetim ortalama görev süresi	3.8yrs
Yönetim Kurulu ortalama görev süresi	5yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Yiwen Zhu'un ücretlendirmesi Hygeia Healthcare Holdings'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	CN¥733m
Mar 31 2024	n/a	n/a	CN¥708m
Dec 31 2023	CN¥2m	CN¥600k	CN¥683m
Sep 30 2023	n/a	n/a	CN¥635m
Jun 30 2023	n/a	n/a	CN¥587m
Mar 31 2023	n/a	n/a	CN¥532m
Dec 31 2022	CN¥4m	CN¥492k	CN¥477m
Sep 30 2022	n/a	n/a	CN¥472m
Jun 30 2022	n/a	n/a	CN¥468m
Mar 31 2022	n/a	n/a	CN¥455m
Dec 31 2021	CN¥709k	CN¥239k	CN¥441m
Sep 30 2021	n/a	n/a	CN¥403m
Jun 30 2021	n/a	n/a	CN¥365m
Mar 31 2021	n/a	n/a	CN¥268m
Dec 31 2020	CN¥45k	CN¥37k	CN¥170m
Sep 30 2020	n/a	n/a	CN¥100m
Jun 30 2020	n/a	n/a	CN¥29m
Mar 31 2020	n/a	n/a	CN¥35m
Dec 31 2019	CN¥779k	CN¥684k	CN¥40m

Tazminat ve Piyasa: Yiwen 'ın toplam tazminatı ($USD 344.08K ) Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 487.65K ).

Tazminat ve Kazançlar: Yiwen 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Yiwen Zhu (60 yo)

3.3yrs

Görev süresi

CN¥2,493,000

Tazminat

Mr. Yiwen Zhu serves as Executive Director & Co-Chief Executive Officer of at Hygeia Healthcare Holdings Co., Limited since August 23, 2021. He serves as Chairman of the Board at Hygeia Healthcare Holdings...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yiwen Zhu	Chairman & Co-CEO	3.3yrs	CN¥2.49m	44.98% HK$ 4.6b
Huanhuan Cheng	Co-CEO & Executive Director	3.3yrs	CN¥1.54m	Veri yok
Wenshan Zhang	Director of Research & Development	4.8yrs	CN¥1.51m	0.0052% HK$ 528.4k
Hui Jiang	Director of Radiotherapy Division & Executive Director	3.9yrs	CN¥1.33m	Veri yok
Ai Ren	Joint Company Secretary	no data	CN¥2.32m	0.46% HK$ 46.8m
Xue Yu	Financial Director	no data	Veri yok	Veri yok
Kwok Yin Lau	Joint Company Secretary	3.8yrs	Veri yok	Veri yok

3.8yrs

Ortalama Görev Süresi

42yo

Ortalama Yaş

Deneyimli Yönetim: 6078 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yiwen Zhu	Chairman & Co-CEO	3.7yrs	CN¥2.49m	44.98% HK$ 4.6b
Huanhuan Cheng	Co-CEO & Executive Director	5.4yrs	CN¥1.54m	Veri yok
Wenshan Zhang	Director of Research & Development	4.8yrs	CN¥1.51m	0.0052% HK$ 528.4k
Hui Jiang	Director of Radiotherapy Division & Executive Director	3.9yrs	CN¥1.33m	Veri yok
Ai Ren	Joint Company Secretary	6.2yrs	CN¥2.32m	0.46% HK$ 46.8m
Changqing Ye	Independent Non-Executive Director	5.2yrs	CN¥240.00k	Veri yok
Chun Zhao	Independent Non-Executive Director	2.5yrs	CN¥240.00k	Veri yok
Yanqun Liu	Independent Non-Executive Director	5.2yrs	CN¥240.00k	Veri yok

5.0yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 6078 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5 yıldır).

Hygeia Healthcare Holdings Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Chairman & Co-CEO recently bought HK$13m worth of stock

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Chairman & Co-CEO recently bought HK$9.0m worth of stock

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Recent updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Chairman & Co-CEO recently bought HK$13m worth of stock

Investor sentiment improves as stock rises 21%

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Investor sentiment deteriorates as stock falls 24%

Chairman & Co-CEO recently bought HK$9.0m worth of stock

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2023 Results on Aug 29, 2023

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into the acquisition agreement to acquire Datang International (Hong Kong) Limited for CNY 1.2 billion.

Now 22% undervalued after recent price drop

Upcoming dividend of CN¥0.15 per share at 0.4% yield

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.71 in FY 2021)

Hygeia Healthcare Holdings Co., Limited has completed a Follow-on Equity Offering in the amount of HKD 791.8 million.

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.

First half 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.32 in 1H 2021)

Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Hygeia Healthcare Holdings Co., Limited Resolves Not to Declare Final Dividend for the Year Ended December 31, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman & Co-CEO recently bought HK$15m worth of stock

Joint Company Secretary recently bought HK$11m worth of stock

Investor sentiment deteriorated over the past week

Chairman & Co-CEO recently bought HK$4.4m worth of stock

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

Board Member recently sold HK$6.2m worth of stock

Director of Research & Development recently sold HK$2.7m worth of stock

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into a share purchase agreement to acquire 98% stake in Suzhou Yongding Hospital from Ascendent Capital Partners I, L.P. managed by Ascendent Capital Partners (Asia) Limited for CNY 1.7 billion.

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş